- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.95 Å
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.2: 8 residues within 4Å:- Chain A: N.156, T.158, I.233
- Chain C: S.210, R.211, P.212, W.213
- Chain J: S.75
2 PLIP interactions:1 interactions with chain C, 1 interactions with chain A- Hydrogen bonds: C:W.213
- Hydrophobic interactions: A:I.233
NAG-NAG-BMA-MAN-MAN.5: 7 residues within 4Å:- Chain C: N.156, T.158, I.233
- Chain E: S.210, R.211, P.212, W.213
2 PLIP interactions:1 interactions with chain E, 1 interactions with chain C- Hydrogen bonds: E:W.213
- Hydrophobic interactions: C:I.233
NAG-NAG-BMA-MAN-MAN.10: 7 residues within 4Å:- Chain A: S.210, P.212, W.213
- Chain E: N.156, T.158, I.233
- Ligands: NAG-NAG.12
2 PLIP interactions:1 interactions with chain E, 1 interactions with chain A- Hydrophobic interactions: E:I.233
- Hydrogen bonds: A:W.213
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.13: 3 residues within 4Å:- Chain A: N.29, T.309
- Chain B: L.52
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.29
NAG.14: 2 residues within 4Å:- Chain A: N.117, T.119
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.117
NAG.20: 2 residues within 4Å:- Chain B: N.154, T.156
No protein-ligand interaction detected (PLIP)NAG.25: 3 residues within 4Å:- Chain C: N.29, T.309
- Chain D: L.52
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.29
NAG.26: 2 residues within 4Å:- Chain C: N.117, T.119
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.117
NAG.30: 2 residues within 4Å:- Chain D: N.154, T.156
No protein-ligand interaction detected (PLIP)NAG.36: 2 residues within 4Å:- Chain F: N.154, T.156
No protein-ligand interaction detected (PLIP)NAG.39: 3 residues within 4Å:- Chain J: N.73, S.75, S.76
2 PLIP interactions:2 interactions with chain J- Hydrogen bonds: J:N.73, J:S.76
NAG.41: 3 residues within 4Å:- Chain L: N.73, S.75, S.76
1 PLIP interactions:1 interactions with chain L- Hydrogen bonds: L:N.73
- 18 x SO4: SULFATE ION(Non-functional Binders)
SO4.15: 2 residues within 4Å:- Chain A: R.48, D.76
Ligand excluded by PLIPSO4.16: 5 residues within 4Å:- Chain A: D.135, S.136
- Chain H: T.58, Y.60, F.70
Ligand excluded by PLIPSO4.17: 4 residues within 4Å:- Chain A: V.93, P.94, D.95, Y.96
Ligand excluded by PLIPSO4.18: 4 residues within 4Å:- Chain A: E.80, Y.96, R.100, R.260
Ligand excluded by PLIPSO4.19: 3 residues within 4Å:- Chain A: K.41, G.266, T.267
Ligand excluded by PLIPSO4.21: 4 residues within 4Å:- Chain B: R.127, H.159, D.160
- Chain D: K.139
Ligand excluded by PLIPSO4.22: 4 residues within 4Å:- Chain B: K.139
- Chain F: R.127, H.159, D.160
Ligand excluded by PLIPSO4.23: 5 residues within 4Å:- Chain A: E.316
- Chain B: W.14, E.15, G.16, R.25
Ligand excluded by PLIPSO4.27: 2 residues within 4Å:- Chain C: R.48, K.74
Ligand excluded by PLIPSO4.28: 5 residues within 4Å:- Chain C: D.135, S.136
- Chain J: T.58, Y.60, T.69
Ligand excluded by PLIPSO4.29: 4 residues within 4Å:- Chain C: N.72, F.111, N.113, R.141
Ligand excluded by PLIPSO4.31: 4 residues within 4Å:- Chain D: R.127, H.159, D.160
- Chain F: K.139
Ligand excluded by PLIPSO4.32: 5 residues within 4Å:- Chain D: G.13, W.14, E.15, G.16, R.25
Ligand excluded by PLIPSO4.34: 5 residues within 4Å:- Chain E: D.135, S.136
- Chain L: T.58, Y.60, F.70
Ligand excluded by PLIPSO4.37: 5 residues within 4Å:- Chain F: G.13, W.14, E.15, G.16, R.25
Ligand excluded by PLIPSO4.38: 3 residues within 4Å:- Chain H: Y.27, T.28, Y.32
Ligand excluded by PLIPSO4.40: 3 residues within 4Å:- Chain J: Y.27, T.28, Y.32
Ligand excluded by PLIPSO4.42: 3 residues within 4Å:- Chain L: Y.27, T.28, Y.32
Ligand excluded by PLIP- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.24: 5 residues within 4Å:- Chain A: K.298
- Chain B: R.54, V.55, L.99
- Chain D: Y.94
5 PLIP interactions:3 interactions with chain B, 2 interactions with chain A- Hydrogen bonds: B:R.54, B:R.54, B:V.55, A:K.298, A:K.298
GOL.33: 4 residues within 4Å:- Chain C: K.298
- Chain D: R.54, L.99
- Chain F: Y.94
4 PLIP interactions:2 interactions with chain D, 2 interactions with chain C- Hydrogen bonds: D:R.54, D:R.54, C:K.298, C:K.298
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lee, P.S. et al., Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity. Proc.Natl.Acad.Sci.USA (2012)
- Release Date
- 2012-10-03
- Peptides
- Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2 chain: BDF
Fab S139/1 light chain: GIK
Fab S139/1 heavy chain: HJL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
EB
BD
DF
FG
LI
MK
NH
HJ
IL
J
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.95 Å
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 5 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 18 x SO4: SULFATE ION(Non-functional Binders)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lee, P.S. et al., Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity. Proc.Natl.Acad.Sci.USA (2012)
- Release Date
- 2012-10-03
- Peptides
- Hemagglutinin HA1 chain: ACE
Hemagglutinin HA2 chain: BDF
Fab S139/1 light chain: GIK
Fab S139/1 heavy chain: HJL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
EB
BD
DF
FG
LI
MK
NH
HJ
IL
J